Genesis Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- Genesis Therapeutics's estimated annual revenue is currently $4.5M per year.
- Genesis Therapeutics's estimated revenue per employee is $112,000
- Genesis Therapeutics has 40 Employees.
- Genesis Therapeutics grew their employee count by 43% last year.
Genesis Therapeutics Competitors & Alternatives
|Competitor Name||Revenue||Number of Employees||Employee Growth||Total Funding||Valuation|
What Is Genesis Therapeutics?
Genesis Therapeutics is an innovative biotechnology company engaging its proprietary molecular AI technology to transform clinical outcomes for patients. The company was founded in 2019 out of Stanford University by Evan Feinberg Ph.D., co-founded by Ben Sklaroff, and backed by Vijay Pande, Ph.D. In addition, Peppi Prasit, Ph.D. leads the Scientific Advisory Board and Leonard Bell, M.D., serves as Chair of the Board of Directors. Its team of technology trailblazers and proven drug developers are driving the discovery and development of novel small molecule drugs to treat patients suffering with severe and debilitating diseases. The company expects to develop drug candidates both internally and selectively in partnership with biopharmaceutical companies. Based in South San Francisco, Genesis Therapeutics received seed funding from Andreessen Horowitz (a16z) and Felicis Ventures. To learn more, visit www.genesistherapeutics.aikeywords:N/A
Number of Employees
Employee Growth %
Genesis Therapeutics News
Omega Therapeutics Announces Appointment of Joshua Reed as Chief ... life from cell genesis, growth, and differentiation to cell death.
|Company Name||Revenue||Number of Employees||Employee Growth||Total Funding|